Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Published laboratory studies have examined BPC-157 in experimental models involving peptide stability, cellular signaling, and tissue-associated pathways
Its safety, efficacy, and pharmacological profile in humans have not been established
In September, the FDAs Cardiovascular and Renal Drugs Advisory Committee voted 9-3 in patisirans favor, but on Monday, Alnylam announced that the regulator had issued a Complete Response Letter in response to its supplemental New Drug Application in this indication
BPC-157 is a synthetic pentadecapeptide derived from a naturally occurring gastric peptide sequence
Offer ends 03.08.26
US$ 20.64
US$ 21.13
US$ 28.21
US$ 20.47
US$ 26.89
US$ 23.23
%20powder-1.png)
US$ 20.46
US$ 23.54
US$ 26.51
